Whole-genome sequencing is a promising approach for human autosomal dominant disease studies. However, the vast number of genetic variants observed by this method constitutes a challenge when trying to identify the causal variants. This is often handled by restricting disease studies to the most damaging variants, e.g. those found in coding regions, and overlooking the remaining genetic variation. Such a biased approach explains in part why the genetic causes of many families with dominantly inherited diseases, in spite of being included in whole-genome sequencing studies, are left unsolved today. Here we explore the use of a geographically matched control population to minimize the number of candidate disease-causing variants without exclu...
We describe three statistical results that we have found to be useful in case-control genetic associ...
In recent years, the advent of genotyping and sequencing technologies has enabled human genetics to ...
Genome and exome sequencing in large cohorts enables characterization of the role of rare variation ...
Whole-genome sequencing is a promising approach for human autosomal dominant disease studies. Howeve...
Whole-genome sequencing is a promising approach for human autosomal dominant disease studies. Howeve...
A major challenge in current exome sequencing in autosomal recessive (AR) families is the lack of an...
A major challenge in current exome sequencing in autosomal recessive (AR) families is the lack of an...
During the past decade, mutations affecting liability to human disease have been discovered at a phe...
To assess factors influencing the success of whole-genome sequencing for mainstream clinical diagnos...
To assess factors influencing the success of whole-genome sequencing for mainstream clinical diagnos...
Recent breakthroughs in exome-sequencing technology have made possible the identification of many ca...
Genome-wide association (GWA) studies have proved extremely successful in identifying novel genetic ...
Genome-wide association (GWA) studies have proved extremely successful in identifying novel genetic ...
Abstract In studies of families with rare disease, it is common to screen for de novo mutations, as ...
Next generation sequencing (NGS) technologies such as whole genome and whole exome sequencing has en...
We describe three statistical results that we have found to be useful in case-control genetic associ...
In recent years, the advent of genotyping and sequencing technologies has enabled human genetics to ...
Genome and exome sequencing in large cohorts enables characterization of the role of rare variation ...
Whole-genome sequencing is a promising approach for human autosomal dominant disease studies. Howeve...
Whole-genome sequencing is a promising approach for human autosomal dominant disease studies. Howeve...
A major challenge in current exome sequencing in autosomal recessive (AR) families is the lack of an...
A major challenge in current exome sequencing in autosomal recessive (AR) families is the lack of an...
During the past decade, mutations affecting liability to human disease have been discovered at a phe...
To assess factors influencing the success of whole-genome sequencing for mainstream clinical diagnos...
To assess factors influencing the success of whole-genome sequencing for mainstream clinical diagnos...
Recent breakthroughs in exome-sequencing technology have made possible the identification of many ca...
Genome-wide association (GWA) studies have proved extremely successful in identifying novel genetic ...
Genome-wide association (GWA) studies have proved extremely successful in identifying novel genetic ...
Abstract In studies of families with rare disease, it is common to screen for de novo mutations, as ...
Next generation sequencing (NGS) technologies such as whole genome and whole exome sequencing has en...
We describe three statistical results that we have found to be useful in case-control genetic associ...
In recent years, the advent of genotyping and sequencing technologies has enabled human genetics to ...
Genome and exome sequencing in large cohorts enables characterization of the role of rare variation ...